Skip to main content
SpringerLink
Log in

Methodological Problems in Assessing Therapeutic Efficacy in Patients with Dementia

  • Leading Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Alzheimer A. Ueber einen eigenartigen, schweren Erkrankungsprozess der Hirnrinde. Neurologisches Centralblatt 25: 1134, 1906

    Google Scholar 

  • Alzheimer A. Ueber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und Psychisch-Gerichtliche Medizin 645: 146–148, 1907

    Google Scholar 

  • Amaducci L, Angst J, Bech P, Benkert O, Bruinvels J, et al. Consensus Conference on the methodology of clinical trials of ‘Nootropics’, Munich, June 1989: report of the Consensus Committee. Pharmacopsychiatry 23: 171–175, 1990

    Article  PubMed  CAS  Google Scholar 

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed. revised (DSM-IIIR), American Psychiatric Association, Washington DC, 1987

    Google Scholar 

  • Anthony JC, LeResche L, Niaz U, von Korff MR, Folstein MF. Limits of the ‘Mini-Mental State’ as a screening test for dementia and delirium among hospital patients. Psychological Medicine 12: 397–408, 1982

    Article  PubMed  CAS  Google Scholar 

  • Crook T, Salama M, Gobert J. A computerized test battery for detecting and assessing memory disorders. In Bes A et al. (Eds) Senile dementias: early detection, pp. 79–85, John Libbey, London, 1986

    Google Scholar 

  • Dahlke F, et al. Recommendations for clinical drug trials in dementia: clinical research working group from the pharmaceutical industry on dementia. Dementia 1: 292–295, 1990

    Google Scholar 

  • Erzigkeit H. The SKT — a short cognitive performance test as an instrument for the assessment of clinical efficacy of cognition enhancers. In Bergener M & Reisberg D (Eds) Diagnosis and treatment of senile dementia, pp. 164–174, Springer, Berlin, 1989

    Chapter  Google Scholar 

  • FDA. Antidementia drug assessment symposium, June 1989. Transcript, Food and Drug Administration, Rockville, MD, 1989

    Google Scholar 

  • Ferris SH, Crook T, Flicker C, Reisberg B, Bartus RT. Assessing cognitive impairment and evaluating treatment effects: psychometric performance tests. In Poon LW (Ed.) Handbook for clinical memory assessment, pp. 139–148, American Psychological Association, Washington, 1986

    Chapter  Google Scholar 

  • Folstein M, Anthony JC, Parhad I, Duffy B, Gruenberg EM. The meaning of cognitive impairment in the elderly. Journal of the American Geriatrics Society 33: 228–235, 1985

    PubMed  CAS  Google Scholar 

  • Galasko D, Klauber MR, Hofstetter CR, Salmon DP, Lasker B, et al. The Mini-Mental State Examination in the early diagnoses of Alzheimer’s disease. Archives of Neurology 47: 49–52, 1990

    Article  PubMed  CAS  Google Scholar 

  • Gräsel E, Cameron S, Lehrl S. What contribution can the Hachinski Ischemic Scale make to the differential diagnosis between multi-infarct dementia and primary degenerative dementia? Archives of Gerontology and Geriatrics 11: 63–75, 1990

    Article  PubMed  Google Scholar 

  • Hachinski VC, Fliff LD, Zilha E, Du Bouhy GH, McAllister VL, et al. Cerebral blood flow in dementia. Archives of Neurology 32: 632–637, 1975

    Article  PubMed  CAS  Google Scholar 

  • Iqbal K, Wang GP, Grundke-Iqbal I, Wisniewski HM. Laboratory diagnostic tests for Alzheimer’s disease. Progress in Clinical and Biological Research 317: 679–687, 1989

    PubMed  CAS  Google Scholar 

  • Israel L, Kosarevic D, Sartorius N. Source book of geriatric assessment, Vols 1 and 2, Karger, Basel-München-Paris, 1984

    Google Scholar 

  • Jarvik LF, Berg L, Bartus R, Heston L, Leith N, et al. Clinical drug trials in Alzheimer disease. What are some of the issues? Alzheimer Disease and Associated Disorders 4: 193–202, 1990

    Article  PubMed  CAS  Google Scholar 

  • Joachim CL, Mori H, Selkoe DJ. Amyloid β-protein deposition in tissues other than brain in Alzheimer’s disease. Nature 341: 226–230, 1989

    Article  PubMed  CAS  Google Scholar 

  • Jorm AF, Scott R, Cullen JS, MacKinnon AJ. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychological Medicine 21: 785–790, 1991

    Article  PubMed  CAS  Google Scholar 

  • Kahn RL, Zarit SH, Hilbert NM, Niederehe GM. Memory complaint and impairment in the aged. Archives of General Psychiatry 32: 1569–1573, 1975

    Article  PubMed  CAS  Google Scholar 

  • Kanowski S, Ladurner G, Maurer K, Oswald WD, Stein U. Empfehlungen zur Evaluierung der Wirksamkeit von Nootropika (Recommendations for the efficacy evaluation of nootropic drugs). Zeitschrift für Gerontopsychologie und -psychiatrie 3: 67–79, 1990

    Google Scholar 

  • Lang CJG. Continuous figure recognition in dementia and unilateral cerebral damage. Neuropsychologia 25: 619–628, 1989

    Article  Google Scholar 

  • Macfadyen DM, Henderson J. Dementia in later life: research and action. In Häfner H et al. (Eds) Mental health in the elderly: a review of the present state of research, pp. 174–181, Springer, Berlin, 1986

    Chapter  Google Scholar 

  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34: 939–944, 1984

    Article  PubMed  CAS  Google Scholar 

  • Morris JC, McKeel Jr DW, Fulling K, Torack RM, Berg L. Validation of clinical diagnostic criteria in senile dementia of the Alzheimer type. Annals of Neurology 24: 17–22, 1988

    Article  PubMed  CAS  Google Scholar 

  • Morris RG, Evenden JL, Sahakian BJ, Robbins TW. Computer-aided assessment of dementia: comparative studies of neuropsychological deficits in Alzheimer-type dementia and Parkinson’s disease. In Stahl M et al. (Eds) Cognitive neurochemistry, pp. 21–36, Oxford University Press, Oxford, 1987

    Google Scholar 

  • Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry 139: 1136–1139, 1982

    PubMed  CAS  Google Scholar 

  • Rosen WG, Mohs RC, David KL. A new rating scale for Alzheimer’s disease. American Journal of Psychiatry 141: 1356–1364, 1984

    PubMed  CAS  Google Scholar 

  • Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. A pathological verification of ischemic score in differentiation of dementias. Annals of Neurology 7: 486–488, 1980

    Article  PubMed  CAS  Google Scholar 

  • Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry 149: 698–709, 1986

    Article  PubMed  CAS  Google Scholar 

  • Satzger W, Engel RR, Ferguson E, Kapfhammer H, Eich FX, et al. Effects of single doses of alpidem, lorazepam, and placebo on memory and attention in healthy young and elderly volunteers. Pharmacopsychiatry 23(Suppl. 3): 114–119, 1990a

    Article  PubMed  Google Scholar 

  • Satzger W, Wagner M, Münzel K, Engel RR. Wirkung von Äthanol, Lorazepam und Scopolamin auf Gedächtnis und Aufmerksamkeit. 32. Tagung experimentell arbeitender Psychologen, Universität Regensburg, 1990b

    Google Scholar 

  • Scogin F, Storandt M, Lott L. Memory-skills training, memory complaints, and depression in older adults. Journal of Gerontology 40: 562–568, 1985

    PubMed  CAS  Google Scholar 

  • Selkoe DJ. Deciphering Alzheimer’s Disease: the amyloid precursor protein yields new clues. Science 248: 1058–1060, 1990

    Article  PubMed  CAS  Google Scholar 

  • Shader RI, Harmatz JS, Salzman C. A new scale for clinical assessment in geriatric populations: Sandoz clinical assessment — geriatric (SCAG). Journal of the American Geriatrics Society 22: 107–113, 1974

    PubMed  CAS  Google Scholar 

  • Spiegel R, Brunner C, Ermini-Fünfschilling D, Monsch A, Notter M, et al. A new behavioral assessment scale for geriatric out-and in-patients: the NOSGER (Nurses’ Observation Scale for Geriatric Patients). Journal of the American Geriatrics Society 39: 339–347, 1991

    PubMed  CAS  Google Scholar 

  • Storandt M, Botwinick J, Danziger WL. Longitudinal changes: patients with mild SDAT and matched healthy controls. In Poon LW (Ed.) Handbook for clinical memory assessment of older adults, pp. 277–284, American Psychological Association, Washington, 1986

    Chapter  Google Scholar 

  • Swash M, Brooks DN, Day NE, Frith CD, Levy R, et al. Clinical trials in Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry 54: 178–181, 1991

    Article  CAS  Google Scholar 

  • Van Riezen H, Segal M. Comparative evaluation of rating scales for clinical psychopharmacology, Elsevier, Basel, Jerusalem, 1988

    Google Scholar 

  • WHO. Tenth revision of the International Classification of Diseases, Chap. V (F): mental, behavioural and certain developmental disorders: clinical descriptions and diagnostic guidelines, World Health Organization, Division of Mental Health, Geneva, 1989

    Google Scholar 

  • Zaudig M, Mittelhammer J, Hiller W, Pauls A, Thora C, et al. SIDAM — A Structured Interview for the diagnosis of Dementia of the Alzheimer type, Multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. Psychological Medicine 21: 225–236, 1991

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychiatric Hospital, University of Munich, Nussbaumstrasse 7, 8000, Munich 2, Federal Republic of Germany

    Rolf R. Engel & Wolfgang Satzger

Authors
  1. Rolf R. Engel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfgang Satzger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Engel, R.R., Satzger, W. Methodological Problems in Assessing Therapeutic Efficacy in Patients with Dementia. Drugs & Aging 2, 79–85 (1992). https://doi.org/10.2165/00002512-199202020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199202020-00001

Search

Navigation